Bkemv Interactions
There are 106 drugs known to interact with Bkemv (eculizumab), along with 5 disease interactions. Of the total drug interactions, 47 are major, 50 are moderate, and 9 are minor.
- View Bkemv disease interactions (5)
Medications known to interact with Bkemv
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- ashwaganda
- atezolizumab
- avelumab
- azathioprine
B
- baricitinib
- bcg
- bcg vaccine
- belimumab
- bifidobacterium infantis
- bifidobacterium longum
- brewer's yeast
C
- canakinumab
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- cholera vaccine, live
- cladribine
- cosibelimab
- crovalimab
D
- dengue vaccine
- denosumab
- deucravacitinib
- deuruxolitinib
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- durvalumab
E
F
G
I
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- infliximab
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- ipilimumab
- iptacopan
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- loncastuximab tesirine
M
N
O
P
R
- retifanlimab
- rilonacept
- ritlecitinib
- rituximab
- roflumilast
- rotavirus vaccine
- rozanolixizumab
- rubella virus vaccine
- ruxolitinib topical
S
T
- tacrolimus topical
- talimogene laherparepvec
- teriflunomide
- tislelizumab
- tofacitinib
- toripalimab
- tremelimumab
- typhoid vaccine, live
U
V
Y
Z
Bkemv disease interactions
There are 5 disease interactions with Bkemv (eculizumab) which include:
Report options
QR code containing a link to this page
More about Bkemv (eculizumab)
- Bkemv consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.